RPG Investment Advisory’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-251
Closed -$5K 376
2020
Q4
$5K Hold
251
﹤0.01% 265
2020
Q3
$4K Hold
251
﹤0.01% 264
2020
Q2
$5K Hold
251
﹤0.01% 248
2020
Q1
$4K Hold
251
﹤0.01% 219
2019
Q4
$5K Hold
251
﹤0.01% 216
2019
Q3
$4K Hold
251
﹤0.01% 222
2019
Q2
$4K Hold
251
﹤0.01% 222
2019
Q1
$5K Buy
+251
New +$5.05K ﹤0.01% 231

Other funds holding TAK

RPG Investment Advisory's TAK Position: Q1 2021 in Review

RPG Investment Advisory sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 251 shares — an estimated $5K sold.

RPG Investment Advisory first reported a position in TAK in Q1 2019 and held it in 8 quarters. The position peaked at $5K in Q4 2020. 316 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

  • RPG Investment Advisory reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • RPG Investment Advisory sold 251 Takeda Pharmaceutical shares in Q1 2021, an estimated $5K.
  • RPG Investment Advisory first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 8 quarters.
  • RPG Investment Advisory's Takeda Pharmaceutical position peaked at $5K in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on RPG Investment Advisory's 13F filing for Q1 2021, filed 27 Apr 2021.